Tunneling nanotubes: A novel pharmacological target for neurodegenerative diseases?

Xiao-Tong Wang,Hua Sun,Nai-Hong Chen,Yu-He Yuan
DOI: https://doi.org/10.1016/j.phrs.2021.105541
IF: 10.334
2021-08-01
Pharmacological Research
Abstract:<p>Diversiform ways of intercellular communication are vital links in maintaining homeostasis and disseminating physiological states. Among intercellular bridges, tunneling nanotubes (TNTs) discovered in 2004 were recognized as potential pharmacology targets related to the pathogenesis of common or infrequent neurodegenerative disorders. The neurotoxic aggregates in neurodegenerative diseases including scrapie prion protein (PrPSc), mutant tau protein, amyloid-beta (Aβ) protein, alpha-synuclein (α-syn) as well as mutant Huntington (mHTT) protein could promote TNT formation via certain physiological mechanisms, in turn, mediating the intercellular transmission of neurotoxicity.</p><p>In this review, we described in detail the skeleton, the formation, the physicochemical properties, and the functions of TNTs, while paying particular attention to the key role of TNTs in the transport of pathological proteins during neurodegeneration.</p>
pharmacology & pharmacy
What problem does this paper attempt to address?